Renata Cardoso
About Renata Cardoso
Renata Cardoso is a Pharmacovigilance Coordinator at Bristol-Myers Squibb in São Paulo, Brazil, with over a decade of experience in the field, including significant roles at Amgen and HRPC.
Current Role at Bristol-Myers Squibb
Renata Cardoso serves as a Pharmacovigilance Coordinator at Bristol-Myers Squibb. She has been in this role for over six years, based in Sao Paulo, Brazil. Her responsibilities likely include overseeing the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problem to ensure patient safety and compliance with regulatory requirements.
Professional Background at Amgen
Renata Cardoso worked at Amgen for a total of five years, where she advanced through progressively responsible positions in drug safety. Starting as a Junior Drug Safety Associate from 2012 to 2014, she was then promoted to Drug Safety Associate, where she served from 2014 to 2016. Finally, she held the position of Senior Drug Safety Associate from 2016 to 2017. Her tenure at Amgen provided her with extensive experience in drug safety and pharmacovigilance.
Early Career and Internships
Renata began her career in pharmacovigilance as an intern at Cristália Produtos Químicos Farmacêuticos Ltda in 2008, working in the Medical Affairs Department. Before that, she had an internship focusing on natural products pharmacology at UNIFESP from 2007 to 2008. These early roles provided her foundational knowledge in medical affairs and pharmacology.
Educational Background
Renata Cardoso has a diverse educational background in pharmacology and related fields. She attended Pós Graduação at Faculdades Oswaldo Cruz from 2009 to 2010 and Universidade Santo Amaro (UNISA) from 2005 to 2008. Additionally, she studied at the Universidade Federal de São Paulo (UNIFESP), which further solidified her expertise in natural products pharmacology.
Experience in Pharmacovigilance and Drug Safety
Renata Cardoso has over a decade of experience in the field of pharmacovigilance and drug safety. She has worked with national and international pharmaceutical companies, holding various roles from intern to coordinator. Her extensive experience includes working at HRPC as 'Analista de Farmacovigilância' from 2009 to 2012, and at Amgen in various capacities before joining Bristol-Myers Squibb. This extensive background has equipped her with a comprehensive understanding of pharmacovigilance processes.